Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CBL |
Variant | R420Q |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | CBL R420Q lies within the RING domain of the Cbl protein (PMID: 17446348). R420Q results in impaired internalization, ubiquitination, and degradation of Egfr and decreased inhibition of Erk1/2 phosphorylation (PMID: 25178484), and disrupts Cbl ubiquitin ligase activity, leading to activation of Flt3 signaling, and is transforming in cell culture in the presence of Flt3 (PMID: 17446348). |
Associated Drug Resistance | |
Category Variants Paths |
CBL mutant CBL exon9 CBL R420Q CBL mutant CBL inact mut CBL R420Q |
Transcript | NM_005188.4 |
gDNA | chr11:g.119278541G>A |
cDNA | c.1259G>A |
Protein | p.R420Q |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_005188 | chr11:g.119278541G>A | c.1259G>A | p.R420Q | RefSeq | GRCh38/hg38 |
NM_005188.3 | chr11:g.119278541G>A | c.1259G>A | p.R420Q | RefSeq | GRCh38/hg38 |
NM_005188.4 | chr11:g.119278541G>A | c.1259G>A | p.R420Q | RefSeq | GRCh38/hg38 |
XM_011543057 | chr11:g.119278541G>A | c.1259G>A | p.R420Q | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|